Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05516342 · ClinicalTrials.gov registry record · NA
LEAD IT! An App to Enable Persons With Early Stage Dementia to Lead Group Activities for Their Peers
A NA study of Alzheimer Disease and Dementia, Vascular, sponsored by Hopeful Aging.
- Completed
- Registry status
- NA
- Development phase
- 182
- Enrollment target
- 1
- Study location
NCT05516342 is a NA study of Alzheimer Disease and Dementia, Vascular that has completed, run by Hopeful Aging. The registered enrollment target is 182 participants, below the 2,750-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05516342, a NA study of Alzheimer Disease and Dementia, Vascular, has completed, sponsored by Hopeful Aging.
- COMPLETED
- Registry status
- NA
- Development phase
- 182 participants
- Enrollment target
- 1
- Study location
Study Summary
The proposed Phase 2 project will involve the further development and evaluation of LEAD IT!, which is a tablet-based app designed to enable persons with dementia to lead activities for their peers (i.e., other persons with dementia). The study will examine the clinical outcomes of long-term use of the app by both Resident Leaders (RLs) and Resident Players (RPs). The Specific Aims of the proposed Phase 2 project are to: 1. Develop improved Beta 1 and Beta 2 Versions of LEAD IT! with sufficient content to facilitate six activities twice per week for 4.5 months. 2. Examine the extent to which RLs are able to serve as leaders while using LEAD IT! 3. Examine the effects of resident-led LEAD IT! programming on RPs. 4. Examine PWD and staff satisfaction with LEAD IT!
Conditions Studied
Interventions
- BEHAVIORAL LEAD IT! Programming
Study Locations (1)
Massachusetts
- The Hearthstone Institute, LLC - Winchester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 182 participants |
| Start Date | 2020-11-10 |
| Est. Completion | 2023-06-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05516342
The ClinicalTrials.gov registry entry for NCT05516342 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 182 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,750-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (93% lower). The listed sponsor is Hopeful Aging, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Alzheimer Disease appearing as the primary indexed condition, and to 1 intervention - of which LEAD IT! Programming is the first listed.
NCT05516342 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT05516342 about?
NCT05516342 is a clinical study titled "LEAD IT! An App to Enable Persons With Early Stage Dementia to Lead Group Activities for Their Peers". The proposed Phase 2 project will involve the further development and evaluation of LEAD IT!, which is a tablet-based app designed to enable persons with dementia to lead activities for their peers (i.e., other persons with dementia). The study will examine the clinical outcomes of long-term use of ...
What is the current status of trial NCT05516342?
This trial is currently completed. It is a NA study. The enrollment target is 182 participants. The study started on 2020-11-10. Estimated completion is 2023-06-11.
What conditions does trial NCT05516342 study?
This clinical trial studies the following conditions: Alzheimer Disease, Dementia, Vascular, Dementia, Mixed.
What interventions are being tested in trial NCT05516342?
The interventions under investigation include: LEAD IT! Programming (BEHAVIORAL).
Who is sponsoring clinical trial NCT05516342?
This trial is sponsored by Hopeful Aging, which has 6 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05516342 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alzheimer Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
I-CARE 2: Mobile Telehealth to Reduce Alzheimer'S-related Symptoms
RECRUITING · NA
-
Brain Outcomes With Lifestyle Change in Down Syndrome
RECRUITING · NA
-
Pulsed Electromagnetic Field Treatment In Patients With Alzheimer's Disease
RECRUITING · NA
-
A Feasiblity Study of Green Activity Program for People Living With Memory Challenges
RECRUITING · NA
-
Connect-Home: Alzheimer's Disease and Related Dementias
RECRUITING · NA
-
Cognitive Vulnerability to Stress in Individuals at Risk for Alzheimer's Disease
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.